For patients dealing with receding gums, sensitivity, or visible root exposure, these treatments offer a path forward that is both effective and far less invasive than many people expect
Most of the real risk comes from unregulated gray-market products rather than properly prescribed ones
GHK-Cu (50mg) is a tripeptide glycyl-L-histidyl-L-lysine bound to a copper(II) ion, first isolated from human plasma in 1973 by Dr
Proper dosing and monitoring minimize these concerns
Before pursuing any peptide therapy, qualified healthcare providers should evaluate your medical history, current medications, baseline biomarkers, and realistic treatment goals
CureCell does not prescribe medications